v3.25.4
Condensed Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Cash Flows from Operating Activities:    
Net loss $ (14,049) $ (8,219)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation 528 1,223
Stock option cancellations 3,732 0
Depreciation and amortization expense 9 135
Issuance of common stock for equity line of credit commitment fee 267 0
Issuance of common stock, net of discount for lack of marketability 0 101
Changes in operating assets - decrease:    
Other current assets 216 675
Changes in operating liabilities - (decrease)/increase:    
Accounts payable 2 (261)
Accrued expenses (95) 597
Net cash used in operating activities (9,390) (5,749)
Cash Flows from Investing Activities:    
Purchase of property and equipment (7) (10)
Net cash used in investing activities (7) (10)
Cash Flows from Financing Activities:    
Gross proceeds from issuance of common stock 3,531 0
Direct financing costs for issuance of common stock (141) 0
Gross proceeds from warrant inducement 2,546 0
Direct transaction costs for warrant inducement (291) 0
Gross proceeds from issuance of pre-funded warrants 4,995 0
Direct financing costs for issuance of pre-funded warrants (450) 0
Gross proceeds from issuance of common stock, pre-funded and common warrants 0 10,025
Direct transaction costs for issuance of common stock, pre-funded and common warrants 0 (1,052)
Gross proceeds from exercise of warrants 5 1
Net cash provided by financing activities 10,195 8,974
Net increase in cash and cash equivalents 798 3,215
Cash and cash equivalents, at beginning of period 9,136 8,608
Cash and cash equivalents, at end of period 9,934 11,823
Non-cash financing activities:    
Recognition of deferred offering costs associated with issuance of common stock (176) 0
Warrants issued for equity issuance costs 0 479
Cashless exercise of warrants 1 39
Direct financing costs included in accounts payable $ 36 $ 0